Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1995 Nov;163(5):463–469.

Unproven (questionable) cancer therapies.

M L Brigden 1
PMCID: PMC1303171  PMID: 8533410

Abstract

More than half of all cancer patients use some form of alternative treatment during the course of their illness. Alternative therapies are often started early in patients' illness, and their use is frequently not acknowledged to health care professionals. Some alternative therapies are harmful, and their promoters may be fraudulent. Persons who try alternative cancer therapies may not be poorly educated but may ultimately abandon conventional treatment. Recent attention has focused on aspects of questionable therapies that make these treatments attractive to patients and that may be perceived as being deficient in the practice of conventional health care professionals. Physicians with patients with cancer should always make sure that unproven therapies are discussed early in the therapeutic relationship. They should also attempt to be aware of alternative therapies that are in vogue in their particular geographic area.

Full text

PDF
463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angell M. Disease as a reflection of the psyche. N Engl J Med. 1985 Jun 13;312(24):1570–1572. doi: 10.1056/NEJM198506133122411. [DOI] [PubMed] [Google Scholar]
  2. Bagenal F. S., Easton D. F., Harris E., Chilvers C. E., McElwain T. J. Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet. 1990 Sep 8;336(8715):606–610. doi: 10.1016/0140-6736(90)93402-b. [DOI] [PubMed] [Google Scholar]
  3. Brigden M. L. Unorthodox therapy and your cancer patient. Postgrad Med. 1987 Jan;81(1):271-2, 275-7, 280. doi: 10.1080/00325481.1987.11699682. [DOI] [PubMed] [Google Scholar]
  4. Campion E. W. Why unconventional medicine? N Engl J Med. 1993 Jan 28;328(4):282–283. doi: 10.1056/NEJM199301283280413. [DOI] [PubMed] [Google Scholar]
  5. Cassileth B. R., Brown H. Unorthodox cancer medicine. CA Cancer J Clin. 1988 May-Jun;38(3):176–186. doi: 10.3322/canjclin.38.3.176. [DOI] [PubMed] [Google Scholar]
  6. Cassileth B. R., Lusk E. J., Guerry D., Blake A. D., Walsh W. P., Kascius L., Schultz D. J. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med. 1991 Apr 25;324(17):1180–1185. doi: 10.1056/NEJM199104253241706. [DOI] [PubMed] [Google Scholar]
  7. Cassileth B. R., Lusk E. J., Miller D. S., Brown L. L., Miller C. Psychosocial correlates of survival in advanced malignant disease? N Engl J Med. 1985 Jun 13;312(24):1551–1555. doi: 10.1056/NEJM198506133122406. [DOI] [PubMed] [Google Scholar]
  8. Cassileth B. R., Lusk E. J., Strouse T. B., Bodenheimer B. J. Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners. Ann Intern Med. 1984 Jul;101(1):105–112. doi: 10.7326/0003-4819-101-1-105. [DOI] [PubMed] [Google Scholar]
  9. Danielson K. J., Stewart D. E., Lippert G. P. Unconventional cancer remedies. CMAJ. 1988 Jun 1;138(11):1005–1011. [PMC free article] [PubMed] [Google Scholar]
  10. Eisenberg D. M., Kessler R. C., Foster C., Norlock F. E., Calkins D. R., Delbanco T. L. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993 Jan 28;328(4):246–252. doi: 10.1056/NEJM199301283280406. [DOI] [PubMed] [Google Scholar]
  11. Ersek M. Stress and cancer: elusive connections. Oncol Nurs Forum. 1986 Sep-Oct;13(5):49–56. [PubMed] [Google Scholar]
  12. Gillick M. R. Common-sense models of health and disease. N Engl J Med. 1985 Sep 12;313(11):700–703. doi: 10.1056/NEJM198509123131120. [DOI] [PubMed] [Google Scholar]
  13. Gordon D. W., Rosenthal G., Hart J., Sirota R., Baker A. L. Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA. 1995 Feb 8;273(6):489–490. doi: 10.1001/jama.273.6.489. [DOI] [PubMed] [Google Scholar]
  14. Green S. A critique of the rationale for cancer treatment with coffee enemas and diet. JAMA. 1992 Dec 9;268(22):3224–3227. [PubMed] [Google Scholar]
  15. Green S. Immunoaugmentative therapy. An unproven cancer treatment. JAMA. 1993 Oct 13;270(14):1719–1723. doi: 10.1001/jama.270.14.1719. [DOI] [PubMed] [Google Scholar]
  16. Guzley G. J. Alternative cancer treatments: impact of unorthodox therapy on the patient with cancer. South Med J. 1992 May;85(5):519–523. doi: 10.1097/00007611-199205000-00012. [DOI] [PubMed] [Google Scholar]
  17. Hauser S. P. Unproven methods in oncology. Eur J Cancer. 1991;27(12):1549–1551. doi: 10.1016/0277-5379(91)90412-7. [DOI] [PubMed] [Google Scholar]
  18. Herbert V. Unproven (questionable) dietary and nutritional methods in cancer prevention and treatment. Cancer. 1986 Oct 15;58(8 Suppl):1930–1941. doi: 10.1002/1097-0142(19861015)58:8+<1930::aid-cncr2820581422>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  19. Herbert V., Yarbro C. H. Nutrition quackery. Semin Oncol Nurs. 1986 Feb;2(1):63–69. doi: 10.1016/0749-2081(86)90011-2. [DOI] [PubMed] [Google Scholar]
  20. Holland J. C. Why patients seek unproven cancer remedies: a psychological perspective. CA Cancer J Clin. 1982 Jan-Feb;32(1):10–14. doi: 10.3322/canjclin.32.1.10. [DOI] [PubMed] [Google Scholar]
  21. Hunter M. Alternative dietary therapies in cancer patients. Recent Results Cancer Res. 1991;121:293–295. doi: 10.1007/978-3-642-84138-5_34. [DOI] [PubMed] [Google Scholar]
  22. Huxtable R. J. The myth of beneficent nature: the risks of herbal preparations. Ann Intern Med. 1992 Jul 15;117(2):165–166. doi: 10.7326/0003-4819-117-2-165. [DOI] [PubMed] [Google Scholar]
  23. Jarvis W. T. Quackery: a national scandal. Clin Chem. 1992 Aug;38(8B):1574–1586. [PubMed] [Google Scholar]
  24. Koff R. S. Herbal hepatotoxicity. Revisiting a dangerous alternative. JAMA. 1995 Feb 8;273(6):502–502. doi: 10.1001/jama.1995.03520300076041. [DOI] [PubMed] [Google Scholar]
  25. Lerner I. J., Kennedy B. J. The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin. 1992 May-Jun;42(3):181–191. doi: 10.3322/canjclin.42.3.181. [DOI] [PubMed] [Google Scholar]
  26. Martin R. W., Duffy J., Engel A. G., Lie J. T., Bowles C. A., Moyer T. P., Gleich G. J. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med. 1990 Jul 15;113(2):124–134. doi: 10.7326/0003-4819-113-2-124. [DOI] [PubMed] [Google Scholar]
  27. McGinnis L. S. Alternative therapies, 1990. An overview. Cancer. 1991 Mar 15;67(6 Suppl):1788–1792. doi: 10.1002/cncr.2820671817. [DOI] [PubMed] [Google Scholar]
  28. Montbriand M. J. Freedom of choice: an issue concerning alternate therapies chosen by patients with cancer. Oncol Nurs Forum. 1993 Sep;20(8):1195–1201. [PubMed] [Google Scholar]
  29. Moulds R. F., McNeil J. J. Herbal preparations--to regulate or not to regulate? Med J Aust. 1988 Dec 5;149(11-12):572–574. doi: 10.5694/j.1326-5377.1988.tb120789.x. [DOI] [PubMed] [Google Scholar]
  30. Norcross W. A., Ganiats T. G., Ralph L. P., Seidel R. G., Ikeda T. S. Accidental poisoning by warfarin-contaminated herbal tea. West J Med. 1993 Jul;159(1):80–82. [PMC free article] [PubMed] [Google Scholar]
  31. Stephens R. Imagery: a strategic intervention to empower clients. Part I--Review of research literature. Clin Nurse Spec. 1993 Jul;7(4):170–174. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES